Home
Issues
Health Partnerships
News & Publications
Influenza
About Us
News Releases
Contact Us
News & Publications
News Releases
Speeches
Publications
Web News & Events Archive
» 2008 Q2 to date
» 2008 Q1
» 2007 Q4
» 2007 Q3
» 2007 Q2
» 2007 Q1
» 2006 Q3 & Q4
Press Contacts
Filter:
Source
Any
Abbott / Boehringer Ingelheim
Accelerating Access Initiative (AAI)
Boehringer Ingelheim GmbH
Bristol-Myers Squibb
Canada's Research-Based Pharmaceutical Companies (Rx&D)
EFPIA
GlaxoSmithKline (GSK)
Hoffmann-La Roche (Roche)
IFPMA
IFPMA - PPHA
IFPMA 2
IFPMA Counterfeiting
IFPMA HSC
IFPMA ITMI
IFPMA IVS
International Council of Nurses (ICN)
International Council of Nurses (ICN) / IFPMA
International Federation of Pharmaceutical Manufacturers & Associations
Medecines for Malaria Venture (MMV)
Novartis
Novartis / MMV
OECD
WHO
WMA / ICN / FIP
Industry Issue
Any
Access to Quality Health Care
Corporate Social Responsibility
Counterfeit Medicines
Ethical Promotion
Health Care Systems
Intellectual Property & Patents
Pharmaceuticals & The Use of the Internet
Regulatory & Scientific Affairs
Research & Development
Trade
Date
Title
18 June 2008
Daiichi-Sankyo Becomes Newest IFPMA Member Company
IFPMA
30 May 2008
IFPMA Appoints Alicia Greenidge as New Director General
IFPMA
23 May 2008
Clinical Trials Portal’s New Pediatric Search Facility Underlines Industry Commitment to Develop Child Medicines Transparently
IFPMA
22 May 2008
IFPMA’s Access & Benefit Sharing Guidelines Support CBD Aims
IFPMA
21 May 2008
R&D Pharmaceutical Companies Mobilize to Help Victims of Natural Disasters in Burma and China
IFPMA
15 May 2008
IFPMA Welcomes Election of New WIPO Director General
IFPMA
28 April 2008
IFPMA Vaccine Task Force Funds University of Cambridge Virus Mapmaker to Help WHO Global Influenza Surveillance Network
IFPMA IVS
24 April 2008
Growing Industry Efforts to Address HIV/AIDS, TB, Malaria, Child & Maternal Health, and Chronic Diseases in Developing Countries
IFPMA
21 April 2008
Pharmaceutical Innovation Platform Publication Describes Policies Which Encourage R&D for Innovative Medicines to Meet Essential Global Health Needs
IFPMA
17 April 2008
IFPMA Director General Dr. Harvey Bale to Retire in June 2008, After More Than a Decade of Service
IFPMA
Items 1 - 10 of 107
1
2
3
4
5
6
7
8
9
10
11